0 projects

H20-HEALTH-Health, demographic change and wellbeing

Up-scaling the global univocal identification of medicines

This innovation action will give a powerful impulse to implementation of ISO IDMP (ID of Medicinal Products) standards in EU Member States drug databases, supporting safe cross-border ePrescription/eDispensation and effective pharmacovigilance. Once EU-interoperable data on medicines taken by pat...

Awarded: NOK 6.1 mill.

Project Period: 2019-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Smart and Healthy Ageing through People Engaging in Supportive Systems

SHAPES aims to create the first European open Ecosystem enabling the large-scale deployment of a broad range of digital solutions for supporting and extending healthy and independent living for older individuals who are facing permanently or temporarily reduced functionality and capabilities. SHA...

Awarded: NOK 5.0 mill.

Project Period: 2019-2023

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

CLoud ARtificial Intelligence For pathologY

Pathology has repeatedly been highlighted as being ripe for innovation in terms of workflow efficiency and more accurate diagnostics. In fact, the estimated market growth for digital pathology systems is huge, with the forecast to reach 143 million dollars by 2019 in the EU and 205 million dollar...

Awarded: NOK 11.5 mill.

Project Period: 2019-2023

Location: Rogaland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Fatigue and sleep disturbances are two common and disabling symptoms that affect patients with neurodegenerative disorders (NDD) and immune-mediated inflammatory diseases (IMID). These symptoms are major predictors of poor quality of life and increased healthcare cost. Current questionnaire-based...

Awarded: NOK 2.3 mill.

Project Period: 2019-2025

Location: Rogaland

H20-MSCA-Marie Sklodowska-Curie actions

Secretion, Autophagy and their role in Neurodegeneration

Neurodegenerative disorders are among the leading causes of mortality and will become more relevant in our continuously aging societies. Most neurodegenerative disorders exhibit alterations in proteostasis, i.e. an imbalance between protein production, sorting and degradation. The secretory and t...

Awarded: NOK 6.7 mill.

Project Period: 2019-2023

Location: Oslo

H20-TWINING-Twinning of research institutions

Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers

Slovakia belongs to countries with the highest incidence of colorectal and pancreatic cancer in Europe. Therefore, the main goal of the VISION proposal is to strengthen the scientific excellence and innovative capacity of Biomedicinske centrum Slovenskej akademie vied (BMC SAV), in early detectio...

Awarded: NOK 1.3 mill.

Project Period: 2019-2023

Location: Viken

H20-MSCA-Marie Sklodowska-Curie actions

Exploitation of the SECRETory pathway for cancer therapy to address European research

Breast and colorectal cancer (BC and CRC) are the most frequent cancers accounting for 19% of all deaths from cancer in Europe. In case of triple-negative BC (TNBC) targeted therapies are not available and non-selective chemotherapy is the only treatment option. Targeted therapy has been approved...

Awarded: NOK 4.6 mill.

Project Period: 2019-2023

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

MARie Curie Intelligent UltraSound

Cardiovascular diseases (CVD) are the number one cause of death in EU. Echocardiography is the most important imaging tool to assess cardiac function, since it is real time, cost effective and can be performed without discomfort and harmful radiation. A typical cardiac ultrasound examination take...

Awarded: NOK 5.8 mill.

Project Period: 2019-2023

Location: Vestfold og Telemark

H20-CROSST-Cross-theme

Clinical validation and production upscaling of a novel product for healing of Pressure Ulcers, Leg Ulcers and Diabetic Foot Ulcers.

A chronic wound (such as Leg Ulcer (LU), Pressure Ulcer (PU) and Diabetic Foot Ulcer (DFU) can be defined as one that has failed to proceed through an orderly and timely reparative process to produce anatomic and functional integrity within a period of 3 months or that has proceeded through the r...

Awarded: NOK 8.5 mill.

Project Period: 2019-2022

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

A nanovaccine Approach for the treatment of Pancreatic Cancer

A Nanovaccine Approach For The Treatment of Pancreatic Cancer By Multicomponent Immuno-Modulation: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths in men and women and still fatal in over 90% of patients. It is characterised by its extremely aggressive nature ...

Awarded: NOK 2.9 mill.

Project Period: 2019-2024

Location: Oslo

H20-SCIENCE-Encourage citizens to engage in science

Science education for action and engagement towards sustainability

The main objective of the Science Education for Action and Engagement Towards Sustainability (SEAS) is to establish, coordinate and evaluate collaboration among six open schooling networks led by universities and science centres with partners in Austria, Belgium, Estonia, Italy, Norway, Sweden, a...

Awarded: NOK 4.7 mill.

Project Period: 2019-2022

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions, SMEs, and 8 major pharmaceutical companies, teamed to study a fundamental issue in medicine: the mechanisms of response and non-response to therapies, the ...

Awarded: NOK 2.0 mill.

Project Period: 2019-2026

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

EXpanding Platforms for Efficacious mRNA Therapeutics

The overall objective of EXPERT is to create an off-the-shelf mRNA-delivering nanomedicine platform that is manufactured via a quality-by-design (QbD) approach with precise nanoparticle characterization and specifications that meet the requirements for GMP scaling up and clinical translation. As ...

Awarded: NOK 11.1 mill.

Project Period: 2019-2025

Location: Trøndelag - Trööndelage

H20-ERC-European Research Council

A woman's reproductive experience: Long-term implications for chronic disease and death

Pregnancy complications such as preeclampsia and preterm birth are known to affect infant health, but their influence on mothers’ long-term health is not well understood. Most previous studies are seriously limited by their reliance on information from the first pregnancy. Often they lack the da...

Awarded: NOK 24.0 mill.

Project Period: 2019-2024

Location: Vestland

H20-MSCA-Marie Sklodowska-Curie actions

Deciphering intrarenal communication to unvail mechanisms of chronic kidney diseases

Chronic kidney disease (CKD) is a major cause of morbidity and mortality, affecting over 10 % of the adult population. Regardless of the primary case, the progressed stage is characterized by scarring of all anatomical elements of the kidney - glomeruli, tubulointerstitium, and vasculature, refer...

Awarded: NOK 2.6 mill.

Project Period: 2019-2022

Location: Vestland

H20-MSCA-Marie Sklodowska-Curie actions

Proton transport and proton-coupled transport

Secure, competitive, and sustainable energy production is a major challenge facing human societies. Biomimetic solutions such as the development of new biofuel cells are hampered by our thus far incomplete understanding of proton transfer reactions. The same holds for health threats to humanity: ...

Awarded: NOK 5.8 mill.

Project Period: 2019-2023

Location: Oslo

H20-ERC-European Research Council

Brains and minds in transition: The dark side of neuroplasticity during sensitive life phases

The potential and boundaries of the human mind is determined by dynamic interactions between the environment and the individual genetic architecture. However, despite several breakthroughs, the genetic revolution has not provided a coherent account of the development of the mind and its disorders...

Awarded: NOK 13.9 mill.

Project Period: 2019-2024

Location: Oslo

H20-ERC-European Research Council

How distress alters opioid drug effects and abuse liability

As the opioid epidemic escalates, we must ask: why are opioids so addictive? Non-human animal research links addiction with the powerful relief opioids can offer to animals in distress. In humans, epidemiological and clinical studies converge upon social stressors and a poor social support networ...

Awarded: NOK 14.4 mill.

Project Period: 2019-2024

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Development of Deep-UV Quantitative Microscopy for the Study of Mitochondrial Dysfunction

Mitochondria play a vital role in the cellular machinery, hence it is little surprising that their dysfunction has been linked to many diseases, from diabetes to neurodegeneration. However, as many studies on the interplay of organelles and molecular dynamics often employ fluorescence microscopy,...

Awarded: NOK 1.9 mill.

Project Period: 2019-2021

Location: Troms og Finnmark - Romsa ja Finnmárku - Tromssa ja Finmarkku

H20-MSCA-Marie Sklodowska-Curie actions

Disability and Disease during the 1918 Influenza Pandemic: Implications for Preparedness Policies

A global influenza pandemic is imminent and public health preparedness plans that address the needs of vulnerable populations are indispensable. While researchers have documented socioeconomic and geographic variables that contribute to disparities in infection and mortality, there has been littl...

Awarded: NOK 1.9 mill.

Project Period: 2019-2021

Location: Oslo

H20-ENV-Climate action, environment, resource efficiency and raw materials

Exposure to heat and air pollution in EUrope – cardiopulmonary impacts and benefits of mitigation and adaptation

Extreme heat and wildland fires are identified as key climate risks in Europe. The two risks are interlinked, as the risk of wildland fires increases during periods of extreme heat and decreasing precipitation. Extreme heat increases the death and disease rates for cardiopulmonary disease (CPD). ...

Awarded: NOK 25.9 mill.

Project Period: 2019-2023

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation

Glioblastoma is not only the most frequent but also the most malignant tumour originating in the Central Nervous System. Due to the extremely complex and heterogeneous molecular biology of this tumour “the same treatment for all” approach does not work well in this disease, and standard of care i...

Awarded: NOK 2.1 mill.

Project Period: 2019-2021

Location: Oslo

H20-EURATOM-EURATOM

Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs

The increasing use of radiation-associated diagnostic and therapeutic procedures have contributed to the improvements of early diagnosis and survival of paediatric patients. While benefits to the patient outweigh the radiation associated risk, the late effects of exposure of children are particul...

Awarded: NOK 3.1 mill.

Project Period: 2019-2024

Location: Oslo og 2 andre

H20-LEIT-LEIT-ICT-Information and Communication Technologies

5G HEalth AquacultuRe and Transport validation trials

Healthcare, transport and food verticals are hugely important in Europe, in terms of jobs, size (collectively surpassing €3Trillion) and export trade. Moreover, they are vital from a social perspective, for better patient outcomes, safer transportation and safer and more sustainable food producti...

Awarded: NOK 23.9 mill.

Project Period: 2019-2022

Location: Viken og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

DNA nanohydrogel loaded Liposomal formulations for high loading efficiency of antimicrobial drugs against intracellular bacterial and topical biofilm infections

Dr. Sybil Obuobi was awarded her PhD in Pharmacy at the National University of Singapore (Singapore) in July 2018 and is very excited to pursue a postdoctoral fellowship at the University of Tromso The Arctic University of Norway (UiT, Norway) under the supervision of Prof. Natasa Skalko-Basnet, ...

Awarded: NOK 2.1 mill.

Project Period: 2019-2022

Location: Troms og Finnmark - Romsa ja Finnmárku - Tromssa ja Finmarkku

H20-MSCA-Marie Sklodowska-Curie actions

SCIENTIA-FELLOWS II: International Postdoctoral Fellowship Programme

The SCIENTIA-FELLOWS II (SF-II) proposal is based on of the FP7-funded SCIENTIA-FELLOWS programme (http://www.med.uio.no/english/research/scientia-fellows/) coordinated by the University of Oslo. The original programme has recruited over 80 researchers and provided excellent training in both rese...

Awarded: NOK 82.5 mill.

Project Period: 2019-2024

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

INnate-ImmunomeTabolIsm as Antiviral TargEt

Viral outbreaks and epidemics continue to impose high morbidity and mortality burdens in mankind and animals, emphasizing the urgent need for the continuous improvement and innovation of our antiviral strategies. The innate immune system is pivotal for effective anti-viral defences. This field is...

Awarded: NOK 2.8 mill.

Project Period: 2019-2023

Location: Trøndelag - Trööndelage

H20-LEIT-LEIT-ICT-Information and Communication Technologies

Advanced packaging for photonics, optics and electronics for low cost manufacturing in Europe

The strong drive for more complex systems and more advanced packaging, including optics and photonics, creates a chance to retain the manufacturing and packaging value chain to Europe - or even start to bring it back. APPLAUSE supports this by building on the European expertise in advanced packag...

Awarded: NOK 5.8 mill.

Project Period: 2019-2022

Location: Oslo og 2 andre

H20-FET-Future and Emerging Technologies

Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies

Deep lying tumours like aggressive brain cancer remain very difficult to treat and existing therapies offer only marginal increase in survival rates. In the case of photomedical therapies they are very effective, but mainly limited by their insufficient depth of light penetration into tissue. Cur...

Awarded: NOK 18.8 mill.

Project Period: 2019-2024

Location: Viken og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to treat Parkinson disease with mild cognitive impairment (PD-MCI). There is ample evidence from epidemiological studies as well as (pre)clinical research that Nic...

Awarded: NOK 0.30 mill.

Project Period: 2019-2022

Location: Oslo og 2 andre